Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer

NCT01193244 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1560

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Orteronel
DRUG: Placebo
DRUG: Prednisone

Sponsor

Millennium Pharmaceuticals, Inc.